Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 15/20 | 0.65 |
| ▸ | SMO | Q99835 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | SETD2 | Q9BYW2 | 1/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7809438 | 0.94 | MAPK14 (0.59) | MAPK14SMOMAPTHTTRAB9A | |
| SCHEMBL7805605 | 0.94 | MAPK14 (0.61) | MAPK14SMOMAPTHTTRAB9A | |
| SCHEMBL6782804 | 0.92 | MAPK14 (0.73) | MAPK14SMOMAPTHTTRAB9A | |
| SCHEMBL7804583 | 0.91 | MAPK14 (0.62) | MAPK14SMOMAPTRAB9ASETD2 | |
| SCHEMBL7799017 | 0.91 | MAPK14 (0.57) | MAPK14SMOMAPTHTTRAB9A | |
| SCHEMBL7804599 | 0.90 | MAPT (0.59) | MAPK14SMOMAPTPOLB | |
| SCHEMBL6484389 | 0.88 | MAPK14 (0.70) | MAPK14SMOMAPTHTTRAB9A | |
| SCHEMBL6478056 | 0.88 | MAPK14 (0.68) | MAPK14SMOMAPTHTTRAB9A | |
| SCHEMBL7806474 | 0.87 | MAPK14 (0.56) | MAPK14SMOMAPTHDAC3HDAC1 | |
| SCHEMBL6485580 | 0.87 | MAPK14 (0.75) | MAPK14SMOMAPTHTTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2001517620-A | — | — | 2001-10-09 | — | — | JP | claimed |
| EP-1017378-A1 | AMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY CYTOKINES | AstraZeneca UK Limited (GB) | 2000-07-12 | — | — | EP | claimed |
| WO-1999015164-A1 | AMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY CYTOKINES | ZENECA LIMITED (GB) | 1999-04-01 | — | — | WO | claimed |
| EP-1017378-A1 | AMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY CYTOKINES | AstraZeneca UK Limited (GB) | 2000-07-12 | — | — | EP | disclosed |
| WO-1999015164-A1 | AMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY CYTOKINES | ZENECA LIMITED (GB) | 1999-04-01 | — | — | WO | disclosed |